Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer (Q80531135)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2007

Language	Label	Description	Also known as
English	Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer	scientific article published on 26 June 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Cristiana Lo Nigro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

O Guérin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

P Formento

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J L Fischel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M C Etienne-Grimaldi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Merlano

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J M Ferrero

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

G Milano

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

26 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

51-57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Evolving Role of Docetaxel in the Management of Androgen Independent Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Future directions in the treatment of androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there a role for chemotherapy in prostate cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I studies of ZD1839 in patients with common solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17593391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-007-0247-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80531135&oldid=2220928222"